Decreased susceptibility to extended-spectrum cephalosporins of a penicillin-susceptible Streptococcus pneumoniae in meningitis. 2000

C De Champs, and J M Constantin, and R Bonnet, and D Guelon, and F Goldstein, and J Sirot
Service de Bactériologie, Faculté de Médecine, Clermont-Ferrand, France. christophe.dechamps@u-clermont1.fr

A 69-year-old woman was admitted to the hospital with meningitis due to Streptococcus pneumoniae. The strain was susceptible to penicillin but intermediate to cefotaxime. In Europe the decrease of susceptibility generally pertains more to penicillin than to cefotaxime. Such a strain is perhaps a forewarning of the existence of high-level cephalosporin-resistant strains. Despite the possible detection of the resistance by oxacillin disk, it underlines the need to determine the MICs of different beta-lactams without delay and to choose the most efficient treatment.

UI MeSH Term Description Entries
D008586 Meningitis, Pneumococcal An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111) Meningitis, Streptococcus pneumoniae,Experimental Pneumococcal Meningitis,Meningitis, Pneumococcal, Experimental,Meningitis, Pneumococcal, Penicillin-Resistant,Meningitis, Pneumococcal, Recurrent,Experimental Pneumococcal Meningitides,Meningitides, Streptococcus pneumoniae,Meningitis, Experimental Pneumococcal,Pneumococcal Meningitides,Pneumococcal Meningitides, Experimental,Pneumococcal Meningitis,Pneumococcal Meningitis, Experimental,Streptococcus pneumoniae Meningitides,Streptococcus pneumoniae Meningitis
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013296 Streptococcus pneumoniae A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals. Diplococcus pneumoniae,Pneumococcus
D018550 Cephalosporin Resistance Non-susceptibility of an organism to the action of the cephalosporins. Cephalosporin Resistances,Resistance, Cephalosporin,Resistances, Cephalosporin

Related Publications

C De Champs, and J M Constantin, and R Bonnet, and D Guelon, and F Goldstein, and J Sirot
January 1997, Acta clinica Belgica,
C De Champs, and J M Constantin, and R Bonnet, and D Guelon, and F Goldstein, and J Sirot
July 1997, The Journal of antimicrobial chemotherapy,
C De Champs, and J M Constantin, and R Bonnet, and D Guelon, and F Goldstein, and J Sirot
May 1994, Antimicrobial agents and chemotherapy,
C De Champs, and J M Constantin, and R Bonnet, and D Guelon, and F Goldstein, and J Sirot
June 1999, Journal of chemotherapy (Florence, Italy),
C De Champs, and J M Constantin, and R Bonnet, and D Guelon, and F Goldstein, and J Sirot
March 1995, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses,
C De Champs, and J M Constantin, and R Bonnet, and D Guelon, and F Goldstein, and J Sirot
January 2003, Journal of clinical microbiology,
C De Champs, and J M Constantin, and R Bonnet, and D Guelon, and F Goldstein, and J Sirot
January 1996, Antimicrobial agents and chemotherapy,
C De Champs, and J M Constantin, and R Bonnet, and D Guelon, and F Goldstein, and J Sirot
January 2013, The National medical journal of India,
C De Champs, and J M Constantin, and R Bonnet, and D Guelon, and F Goldstein, and J Sirot
July 2001, Antimicrobial agents and chemotherapy,
C De Champs, and J M Constantin, and R Bonnet, and D Guelon, and F Goldstein, and J Sirot
October 2002, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!